Mervyn Turner

Mervyn Turner

Presidente presso
Lunac Therapeutics Ltd.
79 anni
Health Technology
Finance
Technology Services

Profilo

Mervyn J.
Turner
is the founder of PrescribeWell, Inc. Current jobs include Chairman at Lunac Therapeutics Ltd., Director at PharmAkea, Inc., Director at EnGeneIC Pty Ltd., Director at Spinogenix, Inc., Director at Amydis, Inc., Director at SAB Sciences, Inc. since 2020, and Board of Strategic Advisor at Excel Medical Ventures LLC.
Former jobs include Director at Preventice Technologies, Inc., Director at Tunitas Therapeutics, Inc., Independent Director at Big Cypress Acquisition Corp., Independent Director at SAB Biotherapeutics, Inc., Independent Director at Adagene, Inc. from 2023 to 2025, Chief Strategy Officer & Senior Vice President at Merck & Co., Inc. in 2011, Chief Strategy Officer at Schering-Plough Corp.
in 2009, Advisor at Quaker Partners Management LP, and Chief Strategy Officer & SVP-Worldwide Licensing at Merck Sharp & Dohme Corp.
from 1999 to 2009.
Education includes a doctorate from The University of Sheffield.

Posizioni attive di Mervyn Turner

SocietàPosizioneInizio
Consulente / Consigliere -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 16/12/2020
Presidente -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Mervyn Turner

SocietàPosizioneFine
ADAGENE INC. Direttore/Membro del Consiglio 24/03/2025
MERCK & CO., INC. Corporate Officer/Principal 03/10/2011
░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Mervyn Turner

Formazione di Mervyn Turner

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

77

Relazioni di 1° grado

18

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private18

Health Technology

Health Technology

Technology Services

Health Technology

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Health Technology

  1. Mercati
  2. Insiders
  3. Mervyn Turner
-40%: Proroga eccezionale
g
:
:
ENTRA ORA